Here we provide the updated version of the guidelines of the European Association for
Palliative Care (EAPC) on the use of opioids for the treatment of cancer pain. The update …

This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …

Background Intravenous (IV) drug delivery is commonly used for its rapid administration and
immediate drug effect. Most studies compare IV to subcutaneous (SC) delivery in terms of …

Background Inherited epidermolysis bullosa (EB) comprises a group of rare disorders that
have multi-system effects and patients present with a number of both acute and chronic pain …

Results: For better understanding, the results are reported in to separate subheadings
including “Parenteral agents” and “Regional blocks”. Non-opioids analgesics such as …

Background: Pain is one of the most common symptoms in cancer patients. The Japanese
Society for Palliative Medicine (JSPM) first published its clinical guidelines for the …

Refractory cancer pain that does not respond to standard opioid and/or co-analgesic therapy
occurs in 10–20% of patients. Risk factors include young age, neuropathic pain type …

Pain is an unpleasant sensory and emotional experience that affects every aspect of a
patient's life and which may be treated through different pharmacological and non …

In recent years, a growing interest in palliative care and in routes of administration other than
oral have prompted more aggressive measures to improve the efficacy of analgesic …

The European Palliative Care Research Collaboration is updating the EAPC
recommendations on opioids in cancer pain management. A systematic literature search on …